TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy

Journal of Surgical Oncology

Volumn 105, Issue 6, 2012, Pages 529-534

  Tanaka, Koji ^a   Saigusa, Susumu ^a   Toiyama, Yuji ^a   Koike, Yuki ^a   Okugawa, Yoshinaga ^a   Yokoe, Takeshi ^a   Inoue, Yasuhiro ^a   Kobayashi, Minako ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

chemoradiotherapy; dihydropyrimidine dehydrogenase; distant recurrence; microdissection; rectal cancer; thymidylate synthase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; FORMALDEHYDE; MESSENGER RNA; OROTATE PHOSPHORIBOSYLTRANSFERASE; PARAFFIN; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE; UFT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MICRODISSECTION; PREDICTION; PREOPERATIVE CHEMORADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; DIHYDROURACIL DEHYDROGENASE (NADP); DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MICRODISSECTION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; OROTATE PHOSPHORIBOSYLTRANSFERASE; PARAFFIN EMBEDDING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

EID: 84859731234     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.22123     Document Type: Article

References (24)

1. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
2. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
3. Guillem JG, Chessin DB, Cohen AM, et al.: Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836.
4. van den Brink M, Stiggelbout AM, van den Hout WB, et al.: Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22: 3958-3964.
5. Collette L, Bosset JF, den Dulk M, et al.: Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007; 25: 4379-4386.
6. Bujko K, Michalski W, Kepka L, et al.: Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Int J Radiat Oncol Biol Phys 2007; 67: 369-377.
7. Díaz-González JA, Calvo FA, Cortés J, et al.: Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation. Int J Radiat Oncol Biol Phys 2006; 64: 1122-1128.
8. Benzoni E, Intersimone D, Terrosu G, et al.: Prognostic value of tumour regression grading and depth of neoplastic infiltration within the perirectal fat after combined neoadjuvant chemo-radiotherapy and surgery for rectal cancer. J Clin Pathol 2006; 59: 505-512.
9. Bertolini F, Bengala C, Losi L, et al.: Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2007; 68: 1455-1461.
10. Rödel C, Martus P, Papadoupolos T, et al.: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696.
11. Chan AK, Wong A, Jenken D, et al.: Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 665-677.
12. Chirieac LR, Swisher SG, Ajani JA, et al.: Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 2005; 103: 1347-1355.
13. Brücher BL, Becker K, Lordick F, et al.: The clinical impact of histopathologic response assessment by residual tumor cell quantification in esophageal squamous cell carcinomas. Cancer 2006; 106: 2119-2127.
14. Patel PR, Mansfield PF, Crane CH, et al.: Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer 2007; 110: 989-995.
15. Rohatgi PR, Mansfield PF, Crane CH, et al.: Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer 2006; 107: 1475-1482.
16. Kusunoki M, Inoue Y, Yanagi H,: Simplification of total mesorectal excision with colonic J-pouch anal anastomosis for middle and lower rectal cancer: One surgeon's experience. Surg Today 2008; 38: 691-699.
17. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 1997; 336: 980-987.
18. Sobin LH, Fleming ID,: TNM Classification of Malignant Tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
19. Dworak O, Keilholz L, Hoffmann A,: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12: 19-23.
20. Bijwaard KE, Aguilera NS, Monczak Y, et al.: Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: Utility in the diagnosis of mantle cell lymphoma. Clin Chem 2001; 47: 195-201.
21. Schneider S, Uchida K, Brabender J, et al.: Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer. J Am Coll Surg 2005; 200: 336-344.
22. Salonga D, Danenberg KD, Johnson M, et al.: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 2000; 6: 1322-1327.
23. Soong R, Shah N, Salto-Tellez M, et al.: Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy. Ann Oncol 2008; 19: 915-919.
24. Jakob C, Liersch T, Meyer W, et al.: Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy. Am J Surg Pathol 2006; 30: 1169-1174.